We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pediatric Trial Plans Should Consider Drug Delivery Options, EC Says
Pediatric Trial Plans Should Consider Drug Delivery Options, EC Says
October 24, 2013
When adding a pediatric indication to a drug product, drugmakers are advised to consider a range of different pharmaceutical forms and formulations that might be more suitable for children, a draft revision to European Commission guidelines on pediatric investigation plans says.